TTNP Stock Summary

• Titan Pharmaceuticals Inc's market capitalization of $2,707,550 is ahead of only 1.32% of US-listed equities.
• Titan Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 2.02% of US listed stocks.
• Titan Pharmaceuticals Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -544.59%, greater than the shareholder yield of merely 0.95% of stocks in our set.
• Stocks that are quantitatively similar to TTNP, based on their financial statements, market capitalization, and price volatility, are OPGN, TTPH, SCON, FCEL, and INFN.
• Visit TTNP's SEC page to see the company's official filings. To visit the company's web site, go to www.titanpharm.com.